BackMetlife Overview
Metlife Inc

Metlife Target Price

Analysts' average 12-month price target for Metlife is $98.

Get informed when a big investor buys or sells

+ Follow

Share Price

$96.51

Average Target Price

$98.361.9% upside

14 analysts in the last 4 months

High: $111 | Low: $86

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-24Morgan StanleyBob Huang$11115% upsideOpen
2026-08-19Wells Fargo$10912.9% upsideOpen
2026-08-06Barclays$970.5% upsideOpen
2026-07-15Atlantic Equities$1036.7% upsideOpen
2026-07-10JefferiesSuneet Kamath$1036.7% upsideOpen
2026-07-08UBSMichael Ward$1058.8% upsideOpen
2026-07-07BarclaysAlex Scott$942.6% downsideOpen
2026-07-06Morgan Stanley$1036.7% upsideOpen
2026-06-24Piper Sandler$906.7% downsideOpen
2026-05-26Piper Sandler$8610.9% downsideOpen
2026-05-21Morgan StanleyBob Huang$933.6% downsideOpen
2026-05-12Wells Fargo$951.6% downsideOpen
2026-05-08Mizuho SecuritiesYaron Kinar$951.6% downsideOpen
2026-05-07BarclaysAlex Scott$933.6% downsideOpen
2026-04-13Mizuho SecuritiesYaron Kinar$933.6% downsideOpen
2026-04-09Evercore ISI$960.5% downsideOpen
2026-04-09UBS$1025.7% upsideOpen
2026-02-12Mizuho Securities$1003.6% upsideOpen
2026-02-10Evercore ISIThomas Gallagher$951.6% downsideOpen
2026-02-05UBS$981.5% upsideOpen
2026-01-14Mizuho Securities$1025.7% upsideOpen
2026-01-13Wells FargoElyse Greenspan$970.5% upsideOpen
2026-01-08UBS$942.6% downsideOpen
2026-01-08Barclays$906.7% downsideOpen
2026-01-06Evercore ISI$970.5% upsideOpen
2025-12-15Mizuho Securities$1014.7% upsideOpen
2025-12-15Morgan Stanley$1014.7% upsideOpen
2025-10-08Barclays$981.5% upsideOpen
2025-10-07Morgan StanleyBob Huang$970.5% upsideOpen
2025-09-19Piper SandlerJohn Barnidge$8413% downsideOpen
2025-09-15Wolfe ResearchTracy Benguigui$951.6% downsideOpen
2025-07-14Morgan StanleyBob Huang$981.5% upsideOpen
2025-04-02Piper SandlerJohn Barnidge$942.6% downsideOpen
2025-02-28Morgan Stanley$10912.9% upsideOpen
2024-10-02Piper SandlerJohn Barnidge$924.7% downsideOpen
2024-09-04BarclaysAlex Scott$915.7% downsideOpen
2024-08-01Bank of America SecuritiesJoshua Shanker$960.5% downsideOpen
2024-07-10Morgan StanleyBob Huang$8314% downsideOpen
2024-05-22Argus ResearchKevin Heal$8017.1% downsideOpen
2024-05-06Piper SandlerJohn Barnidge$8215% downsideOpen
2024-03-13CFRACatherine Seifert$7720.2% downsideOpen
2024-01-08Goldman SachsAlex Scott$8017.1% downsideOpen
2023-09-14Mizuho SecuritiesBrett Linzey$14550.2% upsideOpen
2023-02-02Morgan Stanley$906.7% downsideOpen
2023-01-10Morgan Stanley$888.8% downsideOpen
2023-01-09Goldman Sachs$7819.2% downsideOpen
2023-01-06J.P. Morgan$8017.1% downsideOpen
2022-12-09Jefferies$8215% downsideOpen
2022-11-17Morgan Stanley$879.9% downsideOpen
2022-08-22Credit Suisse$7720.2% downsideOpen

Metlife (MET) FAQ

Metlife posts a target price of $98. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $98 for MET means covering analysts, on average, see the stock 1.9% upside of $96.51 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for MET's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Metlife's other metric pages and overview cover the third.

Judging Metlife against Finance peers is usually better than using a market-wide rule of thumb. Business models inside Finance are more comparable, which makes gaps in target price easier to interpret. Start with $98 here, then scan peer and history charts to see if the gap is persistent.